Tratamiento de las reacciones en el punto de la inyección en pacientes tratados con acetato de glatiramero

Aharoni, 2003, Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ, Proc Natl Acad Sci USA, 100, 14157, 10.1073/pnas.2336171100

Blanchette, 2008, Glatiramer acetate: evidence for a dual mechanism of action, J Neurol, 255, 26, 10.1007/s00415-008-1005-5

Carter, 2010, Glatiramer acetate: a review of its 0use in relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis, Drugs, 70, 1545, 10.2165/11204560-000000000-00000

Soos, 2004, Localized panniculitis and subsequent lipoatrophy with subcutaneous glatiramer acetate (Copaxone) injection for the treatment of multiple sclerosis, Am J Clin Dermatol, 5, 357, 10.2165/00128071-200405050-00009

Soares Almeida, 2006, Localized panniculitis secondary to subcutaneous glatiramer acetate injections for the treatment of multiple sclerosis: a clinicopathologic and immunohistochemical study, J Am Acad Dermatol, 55, 968, 10.1016/j.jaad.2006.04.069

Chang, 1998, Noninvasive mechanical body contouring: (Endermologie) a one-year clinical outcome study update, Aesthetic Plast Surg, 22, 145, 10.1007/s002669900182

Lebrun, 2011, Endermology: a treatment for injection-induced lipoatrophy in multiple sclerosis patients treated with sub cutaneous glatiramer acetate, Clin Neurol Neurosurg, 113, 721, 10.1016/j.clineuro.2011.07.012

Marques, 2011, Impact of a mechanical massage on gene expression profile and lipid mobilization in female gluteofemoral adipose tissue, Obes Facts, 4, 121, 10.1159/000327347